$0.147
-0.0083[-5.31%]
At close: Apr 19
$0.147
0[0.00%]
After Hours: 7:58PM EDT
Pieris Pharmaceuticals
(NASDAQ:PIRS)Latest News for Pieris Pharmaceuticals Stock (NASDAQ:PIRS)
Pieris Pharmaceuticals Stock (NASDAQ: PIRS)
Categories: All
Thursday, April 18, 2024
Wednesday, March 27, 2024
Wednesday, March 20, 2024
Thursday, March 14, 2024
Wednesday, January 31, 2024
Wednesday, December 13, 2023
Wednesday, September 27, 2023
Friday, August 25, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Aug 25, 2023, 1:31PM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Aug 25, 2023, 9:06AM
- Why Affirm Holdings Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving PremarketLisa Levin - Aug 25, 2023, 8:27AM
Thursday, August 24, 2023
Wednesday, August 16, 2023
Tuesday, July 18, 2023
- Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jul 18, 2023, 1:00PM
- Why Pieris Pharmaceuticals Shares Shooting Higher Today?Vandana Singh - Jul 18, 2023, 11:59AM
- Pieris Pharmaceuticals shares are trading higher after the company provided strategic update and announced restructuring.Benzinga Newsdesk - Jul 18, 2023, 9:58AM
- Pieris Pharmaceuticals Shares Resume TradeHappy Mohamed - Jul 18, 2023, 9:50AM
- Pieris Pharma Shares To Resume Trade At 9:50 a.m. ETHappy Mohamed - Jul 18, 2023, 9:23AM
- Pieris Pharmaceuticals Provides Strategic Update And Announces Restructuring; As Part Of Its Cash Preservation Plan, Pieris Initiated A Corporate Restructuring That Will Result In A Reduction Of The Company's Workforce By ~70%Happy Mohamed - Jul 18, 2023, 9:16AM
- Pieris Pharmaceuticals Shares Halted, News PendingBenzinga Newsdesk - Jul 18, 2023, 9:13AM
Monday, June 26, 2023
Friday, June 23, 2023
Thursday, June 22, 2023
Wednesday, June 21, 2023
- Why Are Pieris Pharmaceuticals Shares Tanking TodayVandana Singh - Jun 21, 2023, 9:41AM
- Pieris shares are trading lower after AstraZeneca discontinued Phase 2a trial of Elarekibep for asthma due to disappointing new non-clinical safety findings.Benzinga Newsdesk - Jun 21, 2023, 9:06AM
- Pieris Pharma Shares To Resume Trade At 7:30 AM. ETCharles Gross - Jun 21, 2023, 7:08AM
- Pieris Reports AstraZeneca Discontinuation Of Phase 2a Trial Of Elarekibep (PRS-060/AZD1402) Due To New Non-Clinical Safety Findings From 13-Week Toxicology StudyBenzinga Newsdesk - Jun 21, 2023, 7:04AM
- Pieris Pharmaceuticals Halted; Pending NewsCharles Gross - Jun 21, 2023, 6:58AM
Wednesday, May 31, 2023
- Pieris Pharmaceuticals shares are trading higher after the company was granted EU patent #3322433 for "NOVEL PROTEINS SPECIFIC FOR LAG-3."Benzinga Newsdesk - May 31, 2023, 3:34PM
- Pieris Pharmaceuticals Granted EU Patent #3322433 Today For "Novel Proteins Specific For Lag-3 (Anti-tumor Response For Cancer)"Happy Mohamed - May 31, 2023, 11:48AM
Monday, May 22, 2023
Wednesday, May 10, 2023
- Pieris Pharmaceuticals: Q1 Earnings InsightsBenzinga Insights - May 10, 2023, 10:15AM
- Earnings Scheduled For May 10, 2023Benzinga Insights - May 10, 2023, 9:12AM
- Recap: Pieris Pharmaceuticals Q1 EarningsBenzinga Insights - May 10, 2023, 7:10AM
- Pieris Pharmaceuticals' Cash, Cash Equivalents, And Investments Of $48.4M Sufficient To Fund For More Than The Next 12 MonthsBenzinga Newsdesk - May 10, 2023, 7:09AM
- Pieris Pharmaceuticals Q1 EPS $(0.18) Misses $(0.14) Estimate, Sales $1.94M Miss $6.50M EstimateBenzinga Newsdesk - May 10, 2023, 7:07AM
Tuesday, May 09, 2023
Thursday, May 04, 2023
Thursday, April 13, 2023
Monday, April 10, 2023
Wednesday, March 29, 2023
- Pieris Pharma Pushes Elarekibep Data Readout, Investors React NegativelyVandana Singh - Mar 29, 2023, 3:00PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Mar 29, 2023, 1:31PM
- Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Mar 29, 2023, 12:50PM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Mar 29, 2023, 9:06AM
- Pieris Pharmaceuticals shares are trading lower after the company reported a 17.6% year-over-year decline in revenue in FY22 to $25.9 million.Benzinga Newsdesk - Mar 29, 2023, 8:46AM
- Pieris Pharmaceuticals Clocks 17.6% YoY Revenue Decline In FY22 To $25.9MBenzinga Newsdesk - Mar 29, 2023, 7:38AM